A Phase Ib/II Study of GFH009 Monotherapy in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Condition:   Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Intervention:   Drug: GFH009 Sponsor:   Zhejiang Genfleet Therapeutics Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials